Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

MRIGlobal Wins $54 Million NIH Neurological Disorders And Stroke Contract

By Drug Discovery Trends Editor | January 16, 2015

MRIGlobal announced that it has been awarded a $54 million, 10-year program from the National Institute of Neurological Disorders and Stroke to provide support for the development and manufacturing of drug candidates for ultimate use in human clinical trials.
 
The project entails process development and preparation of active pharmaceutical ingredients (API); pre-formulation and formulation studies; analytical method development and validation; stability studies; drug product manufacturing, packaging, labeling; and storage and distribution of the drug products for clinical trials.
 
“Neurological disorders and stroke impact hundreds of millions of people worldwide,” said Thomas M. Sack, Ph.D., President and Chief Executive Officer of MRIGlobal. “We are honored to support NIH in securing drugs that could literally transform the lives of so many impacted by stroke and a multitude of neurological diseases such as Alzheimer Disease, autism, Parkinson’s Disease, epilepsy, muscular dystrophy, muscular sclerosis, and migraines.” 
 
“This is a very exciting opportunity,” said Roger K. Harris, Ph.D., Associate Vice President, Global Health Security. “While MRIGlobal has worked with the NIH since 1969, this is our first program with the National Institute of Neurological Disorders and Stroke and it opens a new era of collaboration working closely with organizations like University of Kansas, University of Kansas Medical Center, and Kansas City University of Medicine and Biosciences to help bring new treatment and hope to those afflicted with neurological disorders and stroke.” 
 
This project is funded in whole or in part with Federal funds from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN271201500006i.
 
Source: MRIGlobal

Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE